Inflammation, chronic obstructive pulmonary disease and aging

Current Opinion in Pulmonary Medicine

Volumn 17, Issue SUPPL. 1, 2011, Pages

  Provinciali, Mauro ^a   Cardelli, Maurizio ^a   Marchegiani, Francesca ^a  

^a INRCA   (Italy)

Author keywords

aging; chronic obstructive pulmonary disease; inflammation

Indexed keywords

CYTOKINE; MICRORNA;

AGING; ARTICLE; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DNA METHYLATION; EPIGENETICS; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INNATE IMMUNITY; MOLECULAR MECHANICS; PATHOGENESIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TELOMERE;

AGED; AGED, 80 AND OVER; AGING; DNA METHYLATION; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855405206     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/01.mcp.0000410742.90463.1f     Document Type: Article

References (60)

1. Sharma G, Hanania NA, Shim YM. The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009; 6:573-580.
2. Halbert RJ, Natoli JL, Gano A et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28:523-532. (Pubitemid 44794666)
3. Vaz Frangoso CA, Gill TM. Defining chronic obstructive pulmonary disease in an aging population. JAGS 2010; 58:2224-2226.
4. Wouters EF. Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2:26-33. (Pubitemid 40562960)
5. Ito K, Barnes PJ. COPD as a disease of accelerated lung aging. Chest 2009; 135:173-180.
6. Provinciali M, Barucca A, Cardelli M et al. Inflammation, aging, and cancer vaccines. Biogerontology 2010; 11:615-626.
7. Barnes PJ. Cytokine networks in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008; 118:3546-3556.
8. Saetta M, Di Stefano A, Turato G et al. CD81 T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:822-826.
9. O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD81 T lymphocytes with FEV1. Am J Respir Crit Care Med 1997; 155:852-857. (Pubitemid 27133393)
10. Decramer M, Rennard S, Troosters T et al. COPD as a lung disease with systemic consequences: clinical impact, mechanisms, and potential for early intervention. COPD 2008; 5:235-256.
11. Oudijk EJ, Gerritsen WB, Nijhuis EH et al. Expression of priming-associated cellular markers on neutrophils during an exacerbation of COPD. Respir Med 2006; 100:1791-1799. (Pubitemid 44307951)
12. Kundu JK, Surh Y-J. Inflammation: gearing the journey to cancer. Mutat Res 2008; 659:15-30.
13. Ahmad A, Banerjee S, Wang Z et al. Aging and inflammation: etiological culprits of cancer. Curr Aging Sci 2009; 2:174-186.
14. Franceschi C, Capri M, Monti D, Giunta S et al. Inflammaging and antiinflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007; 128:92-105. (Pubitemid 46073065)
15. Fagiolo U, Cossarizza A, Scala E et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 1993; 23:2375-2378. (Pubitemid 23265910)
16. Stowe RP, Peek MK, Cutchin MP, Goodwin JS. Plasma cytokine levels in a population-based study: relation to age and ethnicity. J Gerontol A Biol Sci Med Sci 2010; 65:429-433.
17. Carrieri G,Marzi E,Olivieri F et al. The G/C915 polymorphismof transforming growth factor beta1 is associated with human longevity: a study in Italian centenarians. Aging Cell 2004; 3:443-448. (Pubitemid 40246713)
18. List?̀ F, Candore G, Modica MA,et al. A study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence. Ann N Y Acad Sci 2006; 1089:487-495. (Pubitemid 47092068)
19. Harman D. The free radical theory of aging. Antioxid Redox Signal 2003; 5:557-561. (Pubitemid 37315142)
20. Gerritsen WB, Asin J, Zanen P et al. Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients. Respir Med 2005; 99:84-90. (Pubitemid 40017389)
21. Sitkauskiene B, Serapinas D, Blanco I et al. Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD. Respir Med 2008; 102:1654-1658.
22. Cardelli M, Cavallone L, Marchegiani F et al. A genetic-demographic approach reveals male-specific association between survival and tumor necrosis factor(A/G)-308 polymorphism. J Gerontol A Biol Sci Med Sci 2008; 63:454-460.
23. Zhan P, Wang J, Wei SZ et al. TNF-308 gene polymorphism is associated with COPD risk among Asians: meta-analysis of data for 6118 subjects. Mol Biol Rep 2011; 38:219-227.
24. Zhang S, Wang C, Xi B, Li X. Association between the tumour necrosisfactora-308G/A polymorphism and chronic obstructive pulmonary disease: an update. Respirology 2011; 16:107-115.
25. Zhang L, Chang WW, Ding H et al. Transforming growth factor-b1 polymorphisms and chronic obstructive pulmonary disease: a meta-analysis. Int J Tuberc Lung Dis 2011 Jul 6. [Epub ahead of print]
26. Ito M, Hanaoka M, Droma Y et al. The association of transforming growth factor beta 1 gene polymorphisms with the emphysema phenotype of COPD in Japanese. Intern Med 2008; 47:1387-1394.
27. Olivieri F, Bonafe M, Cavallone L et al. The-174 C/G locus affects in vitro/in vivo IL-6 production during aging. Exp Gerontol 2002; 37:309-314. (Pubitemid 34073548)
28. Có rdoba-Lanú s E, de-Torres JP, Ló pez-Aguilar C et al. Association of IL-6 gene polymorphisms and COPD in a Spanish population. Respir Med 2008; 102:1805-1811.
29. Yanbaeva DG, Dentener MA, Spruit MA,et al. IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study. BMC Med Genet 2009; 9:10-23.
30. Liu SF, Chen YC, Wang CC et al. IL13 promoter (-1055) polymorphisms associated with chronic obstructive pulmonary disease in Taiwanese. Exp Lung Res 2009; 35:807-816.
31. Beghé B, Hall IP, Parker SG et al. Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease. Allergy 2010; 65:474-481.
32. Huang N, Liu L, Wang XZ et al. Association of interleukin (IL)-12 and IL-27 gene polymorphisms with chronic obstructive pulmonary disease in a Chinese population. DNA Cell Biol 2008; 27:527-531.
33. Lee JM, Kang YR, Park SH et al. Polymorphisms in interleukin-1B and its receptor antagonist genes and the risk of chronic obstructive pulmonary disease in a Korean population: a case-control study. Respir Med 2008; 102:1311-1320.
34. Demeo DL, Campbell EJ, Barker AF et al. IL10 polymorphisms are associated with airflow obstruction in severealpha1-antitrypsin deficiency. Am J Respir Cell Mol Biol 2008; 38:114-120.
35. Yoon HI, Silverman EK, Lee HW et al. Lack of association between COPD and transforming growth factor-beta1 (TGFB1) genetic polymorphisms in Koreans. Int J Tuberc Lung Dis 2006; 10:504-509. (Pubitemid 43667637)
36. Hsieh MH, Chong IW, Hwang JJ et al. Lack of associations between several polymorphisms in cytokine genes and the risk of chronic obstructive pulmonary diseases in Taiwan. Kaohsiung. J Med Sci 2008; 24:126-137.
37. Lio D, Scola L, Crivello A et al. Gender-specific association between-1082. IL-10 promoter polymorphism and longevity. Genes Immun 2002; 3:30-33. (Pubitemid 38961103)
38. Lio D, Scola L, Crivello A et al. Allele frequencies of +874T-A single nucleotide polymorphism at the first intron of interferon-gamma gene in a group of Italian centenarians. Exp Gerontol 2002; 37:315-319. (Pubitemid 34073549)
39. Hurme M, Kivimä ki M, Pertovaara M et al. CRP gene is involved in the regulation of human longevity: a follow-up study in Finnish nonagenarians. Mech Ageing Dev 2007; 128:574-576. (Pubitemid 47498520)
40. Balistreri CR, Candore G, Colonna-Romano G et al. Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 2004; 292:2339-2340. (Pubitemid 39491917)
41. Adcock IM, Caramori G, Barnes PJ. Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration 2011; 81:265-284.
42. Sato T, Liu X, Nelson A et al. Reduced miR-146a increases prostaglandin E in chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med 2010; 182:1020-1029.
43. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103:12481-12486. (Pubitemid 44267285)
44. Oglesby IK, McElvaney NG, Greene CM. MicroRNAs in inflammatory lung disease: master regulators or target practice? Respir Res 2010; 11:148-161.
45. Leidinger P, Keller A, Borries A et al. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer 2011; 74:41-47.
46. Asirvatham AJ, Magner WJ, Tomasi TB. miRNA regulation of cytokine genes. Cytokine 2009; 45:58-69.
47. Sheedy FJ, O'Neill LA. Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann Rheum Dis 2008; 67:50-55.
48. Pottelberge GR, Mestdagh P, Bracke KR et al. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 183:898-906.
49. Noren Hooten N, Abdelmohsen K, Gorospe M et al. microRNA expression patterns reveal differential expression of target genes with age. PLoS One 2010; 5:e10724.
50. Ito K, Ito M, Elliott WM et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005; 352:1967-1976. (Pubitemid 40638367)
51. Adenuga D, Yao H, March TH. Histone deacetylase 2 is phosphorylated, ubiquitinated and degraded by cigarette smoke. Am J Respir Cell Mol Biol 2009; 40:464-473.
52. Yang SR, Chida AS, Bauter MR et al. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 2006; 291:L46-L57.
53. Barnes PJ. Role of HDAC2 in the pathophysiology of COPD. Annu Rev Physiol 2009; 71:451-464.
54. Yang SR, Wright J, Bauter M et al. Sirtuin regulates cigarette smoke induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol 2007; 292:L567-L576.
55. Liu F, Killian JK, Yang M et al. Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene 2010; 29:3650-3664.
56. Gonzalo S. Epigenetic alterations in aging. J Appl Physiol 2010; 109:586-597.
57. De S, Michor F. DNA secondary structures and epigenetic determinants of cancer genome evolution. Nat Struct Mol Biol 2011; 18:950-955.
58. Anderson GP, Bozinovski S. Acquired somatic mutations in the molecular pathogenesis of COPD. Trends Pharmacol Sci 2003; 24:71-76. (Pubitemid 36135879)
59. Stribinskis V, Ramos KS. Activation of human long interspersed nuclear element1 retrotransposition by benzo(a)pyrene, an ubiquitous environmental carcinogen. Cancer Res 2006; 66:2616-2620.
60. Savale L, Chaouat A, Bastuji-Garin S et al. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 179:566-571.